Electromed (ELMD) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.00% |
| Dec 31, 2025 | 17.99% |
| Sep 30, 2025 | 32.13% |
| Jun 30, 2025 | 18.71% |
| Mar 31, 2025 | 18.57% |
| Dec 31, 2024 | 10.16% |
| Sep 30, 2024 | 7.52% |
| Jun 30, 2024 | -30.55% |
| Mar 31, 2024 | 31.71% |
| Dec 31, 2023 | 27.37% |
| Sep 30, 2023 | -6.78% |
| Jun 30, 2023 | -27.04% |
| Mar 31, 2023 | 15.66% |
| Dec 31, 2022 | 10.58% |
| Sep 30, 2022 | -15.00% |
| Jun 30, 2022 | 20.84% |
| Mar 31, 2022 | -3.60% |
| Dec 31, 2021 | 8.08% |
| Sep 30, 2021 | 13.24% |
| Jun 30, 2021 | -40.02% |
| Mar 31, 2021 | -19.87% |
| Dec 31, 2020 | 4.84% |
| Sep 30, 2020 | 2.53% |
| Jun 30, 2020 | 35.97% |
| Mar 31, 2020 | 73.80% |
| Dec 31, 2019 | 28.49% |
| Sep 30, 2019 | 27.65% |
| Jun 30, 2019 | -23.61% |
| Mar 31, 2019 | 32.86% |
| Dec 31, 2018 | 33.16% |
| Sep 30, 2018 | 18.63% |
| Jun 30, 2018 | 11.78% |
| Mar 31, 2018 | 23.15% |
| Dec 31, 2017 | 26.93% |
| Sep 30, 2017 | 24.81% |
| Jun 30, 2017 | -37.90% |
| Mar 31, 2017 | 35.64% |
| Dec 31, 2016 | 48.76% |
| Sep 30, 2016 | -8.58% |
| Jun 30, 2016 | 5.74% |
| Mar 31, 2016 | 1.84% |
| Dec 31, 2015 | 18.14% |
| Sep 30, 2015 | 18.75% |